Preclinical Oncology Research
For oncology programs requiring controlled in vivo studies, the contract vivarium model provides a stable research environment with integrated operational support.
Choose a LocationEnabling Breakthroughs in Oncology Research
Built for the practical demands of oncology R&D, Mispro provides controlled, compliant research environments with integrated husbandry, veterinary care, and regulatory oversight services. Scientists maintain direct control of study design and execution while generating reproducible in vivo oncology data that guides early development decisions.
Across our network of AAALAC-accredited contract vivarium facilities, Oncology-focused biotech teams can conduct non-GLP rodent studies supporting target validation, tumor biology, immune response, and therapeutic efficacy.
Contract Vivarium Lab Space for Oncology Research
Biopharma teams advancing novel oncology therapeutics depend on controlled, well managed in vivo research environments to generate reliable efficacy and translational data. Mispro provides research ready vivarium space with integrated animal care and regulatory support, allowing scientists to maintain direct oversight of oncology studies within a professionally operated setting.
Stable Environments for In Vivo Oncology Studies
Mispro's contract vivarium facilities provide a turnkey option for preclinical R&D that keeps studies in-house and in the hands of founding scientists.
Whether your company is pioneering a new drug, is on the forefront of oncology, or has a team of scientists pursuing platform targets, Mispro is an optimal environment for your in vivo drug development research.
Oncology Research Areas Supported
Mispro’s contract vivarium environments support preclinical in vivo oncology research across a wide range of cancer indications and therapeutic approaches, including:
Innovation Across Our Network
- 88% Novel / Proprietary Research
- 58% Translational Programs
- 46% Platform Companies
Mispro vs. CRO
- 6X Increase in study throughput
- 50% Less spend over time
- 70% Reduction in failure rates
From Tumor Models to Study Completion. We're Built for Oncology.
Rigorous animal care and technical precision for the studies that matter most.